Stock Details
BAX is Baxter International Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 75.63$. Average daily volumn in 3 months 3.4M. Market cap 36.87B

Stock symbol : BAX. Exchange : NYSE. Currency : USD
Lastest price : 73.23$. Total volume : 1.70M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Baxter International Inc. (BAX)
Last Price

Previous Close72.60
Day Range72.07-73.29
Bid67.97 x 900
Ask78.17 x 900
Average Volume3.4M
Market Cap36.87B
52 Week Range69.72-89.70
Trailing P/E35.06
Foward P/E15.35
Dividend (Yield %)1.58%
Ex-Dividend Date2022-06-02

Financial Details

According to Baxter International Inc.'s financial reports the company's revenue in 2021 were 12.78B an increase( +9.09%) over the years 2020 revenue that were of 11.67B. In 2021 the company's total earnings were 1.28B while total earnings in 2020 were 1.1B(0%).

Loading ...


Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological... products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Market Cap:
Total Assets:
Total Cash:

News about "Baxter International Inc."


Baxter International Inc. (NYSE:BAX) Expected to Announce Quarterly Sales of $3.89 Billion

Source from : Defense World - 7 days ago

Wall Street brokerages expect Baxter International Inc. (NYSE:BAX โ€“ Get Rating) to announce $3.89 billion in sales for the current fiscal quarter, according to Zacks. Six analysts have provided ...See details»


Baxter International Inc. (NYSE:BAX) Receives Consensus Recommendation of โ€œBuyโ€ from Analysts

Source from : Defense World - 9 days ago

Baxter International Inc. (NYSE:BAX โ€“ Get Rating) has earned an average recommendation of โ€œBuyโ€ from the seventeen ratings firms that are covering the company, reports. One equities ...See details»

Baxter International Inc. (NYSE:BAX) Sees Significant Increase in Short Interest

Source from : ETF Daily News - 6 days ago

Baxter International Inc. (NYSE:BAX โ€“ Get Rating) was the target of a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 7,200,000 shares, ...See details»


BAX July 15th Options Begin Trading

Source from : Nasdaq - 3 days ago

Investors in Baxter International Inc (Symbol: BAX) saw new options begin trading today, for the July 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BAX ...See details»

Baxter International Inc. (BAX) CEO Joe Almeida on Q1 2022 Results - Earnings Call Transcript

Source from : Seeking Alpha - 24 days ago

Good morning, ladies and gentlemen, and welcome to Baxter International's First Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded by Baxter ...See details»

Baxter to Host 2022 Investor Conference

Source from : Associated Press - 12 days ago

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host an investor conference on Wednesday, May 25, 2022 in Glenview, Ill. Chairman and CEO Joe Almeida and other members of Baxterโ€™s ...See details»

Looking Closely at the Growth Curve for Baxter International Inc. (BAX)

Source from : newsheater - 12 days ago

Baxter International Inc. (NYSE:BAX) went up by 1.14% from its latest closing price compared to the recent 1-year high of $89.70. The companyโ€™s stock price has collected 4.26% of gains in the last ...See details»

Baxter International Inc. Q1 Profit Decreases, but beats estimates

Source from : Business Insider - 25 days ago

(RTTNews) - Baxter International Inc. (BAX) reported a profit for first quarter that decreased from last year but beat the Street estimates. The company's bottom line totaled $71 million ...See details»

Baxter International Inc. 2022 Q1 - Results - Earnings Call Presentation

Source from : Seeking Alpha - 23 days ago

Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site ...See details»


Canada Clinical Nutrition Market: Moving Towards a Brighter Future | Abbott Laboratories, Baxter International Inc.

Source from : Digital Journal - 3 days ago

CMI added a new research study on Canada Clinical Nutrition Market in its repository, which aims to offers a detailed overview of the factors influencing ...See details»

Baxter International Inc.: After Strong Q1, Baxter Trims 2022 Outlook on Pump Delay and Supply Chain Issues; Shares Undervalued

Source from : Yahoo Finance - 25 days ago

Baxter offers a variety of medical instruments and supplies to caregivers, and the company enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter ...See details»


Huber Needles Market Is Booming Worldwide 2022-2028 | Baxter International Inc., B. Braun Medical Inc., Smiths Medical, NIPRO Medical Corporation,

Source from : Digital Journal - 9 days ago

A 360-degree overview of the industry is included in the Huber Needles Market report, which includes product introductions, corporate positioning, target ...See details»

Baxter International Lowers FY22 Outlook - Update

Source from : Business Insider - 25 days ago

(RTTNews) - While reporting financial results for the first quarter on Thursday, health care company Baxter International Inc. (BAX) lowered its earnings, adjusted earnings and sales growth for ...See details»


Biz Buzz: North Central Medical Supply & Equipment breaks ground on new building project

Source from : Brainerd Dispatch - 12 hours ago

Gretchen Rogers, North Central Medical Supply president and CEO, said the companyโ€™s 10-year lease in its current location in Brainerd ends this year and they found the perfect location to build.See details»